Haemonetics Corporation
79.91
0.50 (0.63%)
At close: Jan 14, 2025, 3:59 PM
80.40
0.61%
Pre-market Jan 15, 2025, 05:16 AM EST

Haemonetics Corporation Revenue Breakdown

Quarter Sep 28, 2024Apr 3, 2021Dec 29, 2018Sep 29, 2018Jun 30, 2018Mar 31, 2018Dec 30, 2017Sep 30, 2017Jul 1, 2017Apr 1, 2017Dec 31, 2016Oct 1, 2016Jul 2, 2016Sep 27, 2014Jun 28, 2014
Blood Center Revenue 68.80M 72.92M 67.16M 68.24M 64.48M 73.40M 74.23M 71.71M 65.56M 82.32M 76.35M 74.27M 70.94M 83.28M 86.37M
Blood Center Revenue Growth -5.65% +8.59% -1.59% +5.83% -12.15% -1.11% +3.51% +9.37% -20.36% +7.82% +2.81% +4.69% -14.82% -3.57% n/a
Hospital Revenue 138.38M 83.75M 48.38M 48.99M 47.96M 111.58M 113.10M 109.77M 101.51M 100.86M 108.66M 103.56M 97.65M 30.61M 30.60M
Hospital Revenue Growth +65.24% +73.11% -1.24% +2.14% -57.02% -1.34% +3.03% +8.14% +0.64% -7.18% +4.92% +6.06% +219.05% +0.02% n/a
Plasma Revenue 138.56M n/a 131.82M 124.35M 116.90M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Plasma Revenue Growth n/a n/a +6.01% +6.37% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Mar 30, 2024Apr 1, 2023Apr 2, 2022Apr 3, 2021Mar 28, 2020Mar 30, 2019Mar 31, 2018Apr 1, 2017Apr 2, 2016Mar 28, 2015Mar 29, 2014Mar 30, 2013Mar 31, 2012
Asia Revenue 107.54M 104.14M 110.80M 105.82M 109.30M 118.70M 115.13M 109.86M 111.76M 88.30M 108.68M 120.73M 124.38M
Asia Revenue Growth +3.27% -6.02% +4.71% -3.18% -7.92% +3.10% +4.80% -1.70% +26.57% -18.75% -9.98% -2.94% n/a
Europe Revenue 160.14M 156.68M 163.52M 159.08M 153.35M 164.50M 164.23M 166.01M 187.72M 494.79M 500.72M 454.87M 352.16M
Europe Revenue Growth +2.21% -4.18% +2.79% +3.74% -6.78% +0.17% -1.07% -11.57% -62.06% -1.18% +10.08% +29.17% n/a
Japan Revenue 58.09M 61.30M 75.56M 77.68M 72.22M 69.91M 67.32M 79.27M 81.41M n/a n/a n/a n/a
Japan Revenue Growth -5.23% -18.88% -2.72% +7.56% +3.30% +3.85% -15.07% -2.63% n/a n/a n/a n/a n/a
Other Country Or Region Revenue 13.28M 3.65M 3.99M 5.28M 7.42M 7.62M 8.52M 8.30M 8.50M n/a n/a n/a n/a
Other Country Or Region Revenue Growth +263.62% -8.45% -24.47% -28.75% -2.72% -10.54% +2.66% -2.34% n/a n/a n/a n/a n/a
United States Revenue 970.01M 842.90M 639.32M 522.61M 646.20M 606.85M 548.73M 522.69M 519.44M n/a n/a n/a n/a
United States Revenue Growth +15.08% +31.84% +22.33% -19.13% +6.49% +10.59% +4.98% +0.62% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 28, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Oct 1, 2022Jul 2, 2022Apr 2, 2022Jan 1, 2022Oct 2, 2021Jul 3, 2021Apr 3, 2021Dec 26, 2020Sep 26, 2020Jun 27, 2020Mar 28, 2020Dec 28, 2019Sep 28, 2019Jun 29, 2019Mar 30, 2019Dec 29, 2018Sep 29, 2018Jun 30, 2018Mar 31, 2018Dec 30, 2017Sep 30, 2017Jul 1, 2017Apr 1, 2017Dec 31, 2016Oct 1, 2016Jul 2, 2016Apr 2, 2016Dec 26, 2015Sep 26, 2015Jun 27, 2015Mar 28, 2015
Selling, General, and Administrative Revenue 106.95M 107.98M 106.44M 111.71M 104.90M 93.48M 97.38M 94.66M 92.41M 92.23M 91.84M 80.73M 75.78M 91.22M 83.71M 73.45M 71.70M 69.54M 78.57M 78.27M 69.84M 73.00M 78.61M 73.88M 77.25M 68.55M 79.02M 97.86M 72.78M 66.86M 73.09M 70.96M 71.12M 87.50M 83.02M 78.94M 74.56M 87.61M 79.60M
Selling, General, and Administrative Revenue Growth -0.96% +1.45% -4.72% +6.49% +12.21% -4.00% +2.87% +2.43% +0.20% +0.42% +13.77% +6.53% -16.93% +8.97% +13.98% +2.44% +3.11% -11.50% +0.39% +12.07% -4.33% -7.13% +6.40% -4.36% +12.70% -13.26% -19.24% +34.45% +8.86% -8.52% +3.00% -0.23% -18.72% +5.39% +5.17% +5.87% -14.89% +10.06% n/a
Research and Development Revenue 16.53M 14.46M 13.99M 13.27M 12.66M 12.65M 15.64M 12.69M 10.90M 10.90M 13.21M 10.04M 10.85M 12.70M 10.84M 7.50M 6.76M 7.75M 8.97M 7.00M 7.42M 7.49M 8.75M 8.98M 8.58M 9.41M 11.09M 12.43M 7.52M 8.19M 9.32M 8.46M 8.34M 11.44M 11.75M 10.94M 11.55M 11.32M 17.23M
Research and Development Revenue Growth +14.31% +3.34% +5.50% +4.74% +0.13% -19.15% +23.29% +16.46% -0.06% -17.47% +31.61% -7.52% -14.55% +17.14% +44.55% +10.91% -12.74% -13.64% +28.20% -5.69% -0.87% -14.40% -2.57% +4.60% -8.75% -15.16% -10.78% +65.23% -8.20% -12.10% +10.15% +1.51% -27.11% -2.66% +7.38% -5.29% +2.05% -34.28% n/a